Potential new treatment for drug addiction relapse revealed

June 12, 2018, University of Bath

Research published in Addiction Biology by scientists at the University of Bath reveals a new potential mechanism for combatting drug addiction relapse.

Relapsing into drug taking is a big problem in treating , where the majority of addicts return to drug-taking within 12 months of quitting. This is brought into focus by the burgeoning 'opioid epidemic' of prescription as well as recreational opioid drugs, such as morphine and heroin. Addiction is associated with drug-related cues such as places, drug paraphernalia, the drug itself, or stress, highlighting that memories play a key role in addiction relapse.

In this study researchers at Bath, working with colleagues from the University of Surrey and RenaSci, used an to study relapse to morphine seeking behaviour. Rats or mice learned to associate particular environmental cues with morphine. After removal of the drugs, relapse back to drug-seeking behaviour occurred in response to getting the cues again.

The Bath team wanted to test the effect of using a blocker for a brain neurotransmitter called acetylcholine, which is involved in processes. They tested the effect of a blocker of a specific receptor for acetylcholine—the alpha7 nicotinic receptor—to see if this might impair relapse. This drug, methyllycaconitine (MLA), that comes from Delphinium plants, selectively blocked morphine relapse (but not the initial learning to seek drugs), in both mice and rats.

This exciting novel observation led the researchers to investigate the brain region responsible for MLA's effect and identified the ventral hippocampus as the locus. The hippocampus is well known for its role in memory, and the ventral domain is particularly associated with emotional memories, an obvious link to addiction pathways.

Professor Sue Wonnacott, from the University of Bath's Department of Biology & Biochemistry, said: "It's an exciting step forward that links the cholinergic system, more commonly associated with nicotine addiction, with the mechanisms of relapse a different class of abused drug—the opioids. More work needs to be done to uncover the brain mechanisms involved, but it raises the prospect of erasing long-term -associated memories that underpin addiction and the propensity to relapse."

Dr. Chris Bailey, from the University of Bath's Department of Pharmacy & Pharmacology, commented: "Drug addiction is very poorly treated at present so this potential novel approach is very welcome. An important next step is to see if MLA blocks relapse to other abused drugs. We already have evidence, in the same animal model, that it is effective against the more potent opioid, heroin. If MLA has similar effects against other drugs of abuse such as cocaine it would be even more encouraging."

Explore further: Brain mechanisms in drug addiction—new brain pathways revealed

More information: Victoria L. Wright et al, Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine-conditioned place preference and associated changes in AMPA receptor binding, Addiction Biology (2018). DOI: 10.1111/adb.12624

Related Stories

Brain mechanisms in drug addiction—new brain pathways revealed

November 24, 2016
UNSW researchers have identified new brain pathways linked to addiction and shown that by manipulating them, drug seeking behaviour and motivation for alcohol can be reduced.

Non-psychoactive cannabis ingredient could help addicts stay clean

March 23, 2018
A preclinical study in rats has shown that there might be value in using a non-psychoactive and non-addictive ingredient of the Cannabis sativa plant to reduce the risk of relapse among recovering drug and alcohol addicts. ...

Could targeting oxtyocin help treat opioid addiction?

April 5, 2017
A new review of published research indicates that the oxytocin system—a key player in social reward and stress regulation—is profoundly affected by opioid use. Therefore, it may be an important target for developing medications ...

Researchers identify brain mechanism linking PTSD and opioid addiction

April 23, 2018
Researchers at Western University have shown that the recall of traumatic memories enhances the rewarding effects of morphine, shedding light on the neurobiological link between post-traumatic stress disorder (PTSD) and opioid ...

In rats that can't control glutamate, cocaine is less rewarding, staving off relapse

July 11, 2017
Rats missing a neuroreceptor that controls the release of the neurotransmitter glutamate are less amenable to the rewarding effects of cocaine, increasing their chance of kicking the habit once addicted, researchers from ...

Recommended for you

Exercise helps treat addiction by altering brain's dopamine system

May 28, 2018
New research by the University at Buffalo Research Institute on Addictions has identified a key mechanism in how aerobic exercise can help impact the brain in ways that may support treatment—and even prevention strategies—for ...

Warning labels on alcohol containers highly deficient, new research shows

May 21, 2018
Current health warning labels on alcohol beverage containers in New Zealand are highly deficient, new research from the University of Otago, Wellington shows.

Serving smaller alcoholic drinks could reduce the U.K.'s alcohol consumption

May 14, 2018
New research published in Addiction, conducted by researchers from the Universities of Liverpool and Sheffield, highlights the potential benefits of reducing the standard serving size of alcoholic beverages.

Anti-alcoholism drug shows promise in animal models

May 3, 2018
Scientists at The University of Texas at Austin have successfully tested in animals a drug that, they say, may one day help block the withdrawal symptoms and cravings that incessantly coax people with alcoholism to drink. ...

FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help addicted people break the habit

April 28, 2018
Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances. Moreover, relapse rates hover between 40 and 60 percent, similar to rates ...

Buprenorphine may be safer than methadone if treatment duration is longer, study suggests

April 20, 2018
The less commonly prescribed opioid substitute buprenorphine may be safer than methadone for problem opioid users, especially if used during the first month of treatment, according to a study which includes University of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.